English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Advanced Psychiatric Therapeutics Clinic offers esketamine and transcranial magnetic stimulation (TMS) for patients with treatment-resistant depression.
Tag: Major Depressive Disorder
ACP reviews performance measures for major depressive disorder
A review by the American College of Physicians (ACP) of performance measures designed to evaluate quality of care for those suffering from major depressive disorder (MDD) found only one of eight measures relevant to internal medicine physicians to be valid. The paper is published in Annals of Internal Medicine.
Formerly depressed patients continue to focus on negative
People who have recovered from a major depressive episode, when compared with individuals who have never experienced one, tend to spend more time processing negative information and less time processing positive information, putting them at risk for a relapse, according to research published by the American Psychological Association.
Spotlight: Maternal Mental Health Month
Most new mothers experience one or more changes in their mood before childbirth and for two weeks after the baby arrives.
Accelerated delivery of transcranial magnetic stimulation is safe and effective
Accelerated schedules for repetitive transcranial magnetic stimulation (rTMS) can be offered to patients experiencing treatment-resistant major depressive disorder (MDD), a group of clinician–researchers and neuroscientists have concluded. The group cautions that such treatment should be proposed only after detailed discussion with patients about acceleration being an alternate form of rTMS scheduling, with documentation of informed consent.
American College of Physicians recommends cognitive behavioral therapy or second-generation antidepressants for adults with major depressive disorder
The American College of Physicians (ACP) has issued an update of its guideline with clinical recommendations for nonpharmacologic and pharmacologic treatments of adults in the acute phase of major depressive disorder (MDD). In the updated clinical guideline, ACP recommends the use of either cognitive behavioral therapy (CBT) or second-generation antidepressants (SGAs) as initial treatment in adults with moderate to severe MDD, and suggests the combination of both, as an alternate initial treatment option. The guideline and supporting evidence reviews are published in Annals of Internal Medicine.
Engineering Research Provides Non-Invasive Solutions for Diagnosing and Treating Neurological and Psychiatric Conditions
Could artificial intelligence help solve the mental health crisis? What if an algorithm allowed neurologists to know the area affected by a brain seizure? These are just a few of the questions that Maryam Ravan, Ph.D., assistant professor of electrical and…
Mount Sinai Launches the Brain and Body Research Center, Among the First in the U.S.to Focus Solely on How the Brain and Body Interact
Have you ever experienced a stressful time in your life and then caught a cold, or wondered why you feel sad and depressed when you’re sick? It turns out that it’s not all in your head.
Recent research spanning the fields of neuroscience and immunology suggests that when the brain senses a threat in the environment—whether it be physical, psychological, or social—it sends signals via a complex network of peripheral nerves that mobilize the immune system, readying it to protect us from injury.
Metabolism May Play Role in Recurrent Major Depression
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive indicators for persons at risk for recurrent major depressive disorder.
Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.
Adult stem cell study shows fish oil may help with depression
A study published in Molecular Psychiatry shows that patient-derived adult stem cells can be used to model major depressive disorder and test how a patient may respond to medication and that fish oil, when tested in the model, created an antidepressant response.
Mental Health Care Needed More Than Ever During COVID-19 Pandemic — Telehealth Can Help Make it Happen
Live video telehealth services are a critical component of the COVID-19 response. Offered by physicians, other clinicians and health-care organizations, telehealth provides a useful method for starting and continuing essential mental health treatment without risk of spreading infection.